Clinical Trial

The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-7117 in Chinese healthy subjects.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-27; most recent amendment 2026-04-01.
Status change: Active, Not Recruiting → Completed 2025-08-20
Status change: Recruiting → Active, Not Recruiting 2025-07-31
Status change: Not Yet Recruiting → Recruiting 2025-07-07
Trial Details
NCT Number NCT06994286
Lead Sponsor Tanabe Pharma Corporation
Conditions Healthy Subjects
Enrollment 40 participants
Start Date 2025-06-24
Primary Completion 2025-07-21 (estimated)
Study Completion 2025-08-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-03